FibroBiologics, Inc. (FBLG)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Oct 23, 16:00
0.9643
+0.01
(+1.51%)
Pre-Market: 20:00
FibroBiologics EPS Diluted (Quarterly) : -0.6564 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6564 |
| March 31, 2026 | -1.325 |
| December 31, 2025 | -0.9754 |
| September 30, 2025 | -2.683 |
| June 30, 2025 | -2.411 |
| March 31, 2025 | -0.1354 |
| December 31, 2024 | -1.822 |
| September 30, 2024 | -0.0149 |
| Date | Value |
|---|---|
| June 30, 2024 | 0.0274 |
| March 31, 2024 | -0.2586 |
| December 31, 2023 | -0.3442 |
| September 30, 2023 | -0.0675 |
| June 30, 2023 | -1.330 |
| March 31, 2023 | -0.1524 |
| December 31, 2022 | -0.938 |
| September 30, 2022 | -0.0481 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.117M |
| Total Expenses (Quarterly) | 4.117M |
| Enterprise Value | 3.724M |
| Earnings Yield | -593.7% |
| Normalized Earnings Yield | -556.25 |